Published in Can Assoc Radiol J on February 13, 2013
Bilateral synchronous low-grade adenosquamous carcinoma of the breast: A Case report with review of the current literature. Int J Surg Case Rep (2015) 0.77
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol (2010) 14.41
Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol (2010) 5.44
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med (2010) 4.38
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer. J Clin Oncol (2012) 4.14
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med (2010) 2.72
Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis. Clin Chem (2005) 1.86
Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement. Am J Surg Pathol (2012) 1.83
Active surveillance is the preferred approach to clinical stage I testicular cancer. J Clin Oncol (2013) 1.81
Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma. Clin Cancer Res (2004) 1.67
Impact of routine pathology review on treatment for node-negative breast cancer. J Clin Oncol (2012) 1.59
Is mastectomy superior to breast-conserving treatment for young women? Int J Radiat Oncol Biol Phys (2007) 1.58
Reducing patient wait times and improving resource utilization at British Columbia Cancer Agency's ambulatory care unit through simulation. Health Care Manag Sci (2009) 1.54
Population-based outcomes after whole brain radiotherapy and re-irradiation in patients with metastatic breast cancer in the trastuzumab era. Radiat Oncol (2011) 1.51
Acute cardiotoxicity with concurrent trastuzumab and radiotherapy including internal mammary chain nodes: a retrospective single-institution study. Radiother Oncol (2008) 1.49
Postmastectomy radiation therapy after immediate two-stage tissue expander/implant breast reconstruction: a University of British Columbia perspective. Plast Reconstr Surg (2014) 1.47
Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV. J Mol Diagn (2007) 1.31
A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma. Genes Chromosomes Cancer (2004) 1.24
Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade. Mod Pathol (2006) 1.19
Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum Pathol (2003) 1.16
Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias. Int J Radiat Oncol Biol Phys (2003) 1.15
Population-based outcomes after brain radiotherapy in patients with brain metastases from breast cancer in the Pre-Trastuzumab and Trastuzumab eras. Radiat Oncol (2013) 1.14
A population-based study of the fractionation of postlumpectomy breast radiation therapy. In regard to Ashworth et al. Int J Radiat Oncol Biol Phys (2013) 1.13
The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. Am J Surg Pathol (2012) 1.09
Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy. J Clin Oncol (2008) 1.08
Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. Clin Chem (2005) 1.07
Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter? BJU Int (2012) 1.06
Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy. Int J Radiat Oncol Biol Phys (2004) 1.05
Outcomes in patients treated with mastectomy for ductal carcinoma in situ. Int J Radiat Oncol Biol Phys (2012) 1.03
Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance. Cancer Med (2014) 1.01
Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer. BJU Int (2007) 0.99
Effect of community population size on breast cancer screening, stage distribution, treatment use and outcomes. Can J Public Health (2012) 0.98
Operations research methods improve chemotherapy patient appointment scheduling. Jt Comm J Qual Patient Saf (2012) 0.97
Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and older: does age determine survival after radical treatment? J Thorac Oncol (2010) 0.95
A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes. J Clin Oncol (2011) 0.94
Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada. Int J Cancer (2014) 0.94
Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen. Cancer (2008) 0.93
Regional radiotherapy to axilla and supraclavicular fossa for adjuvant breast treatment: a comparison of four techniques. Int J Radiat Oncol Biol Phys (2004) 0.92
Canadian consensus guidelines for the management of testicular germ cell cancer. Can Urol Assoc J (2010) 0.92
Effect of nodal irradiation and fraction size on cardiac and cerebrovascular mortality in women with breast cancer treated with local and locoregional radiotherapy. Int J Radiat Oncol Biol Phys (2010) 0.91
Three-year outcomes of a Canadian multicenter study of accelerated partial breast irradiation using conformal radiation therapy. Int J Radiat Oncol Biol Phys (2010) 0.91
Does the intent to irradiate the internal mammary nodes impact survival in women with breast cancer? A population-based analysis in British Columbia. Int J Radiat Oncol Biol Phys (2012) 0.91
Population-based study of cardiovascular mortality among patients with prostate cancer treated with radical external beam radiation therapy with and without adjuvant androgen deprivation therapy at the British Columbia Cancer Agency. Int J Radiat Oncol Biol Phys (2010) 0.89
Skin-sparing mastectomy and immediate autologous breast reconstruction in locally advanced breast cancer patients: a UBC perspective. Ann Surg Oncol (2011) 0.88
Defining the need for radiotherapy for lung cancer in the general population: a criterion-based, benchmarking approach. Med Care (2003) 0.88
Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer. Cancer (2012) 0.88
The impact of hypofractionated whole breast radiotherapy on local relapse in patients with Grade 3 early breast cancer: a population-based cohort study. Int J Radiat Oncol Biol Phys (2011) 0.86
Histotype-genotype correlation in 36 high-grade endometrial carcinomas. Am J Surg Pathol (2013) 0.85
Facilitated "fast track" referral reduces time from abnormal screening mammogram to diagnosis. Can J Public Health (2008) 0.85
Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases. Support Care Cancer (2010) 0.84
A national survey of the availability of intensity-modulated radiation therapy and stereotactic radiosurgery in Canada. Radiat Oncol (2012) 0.83
Are the creation and maintenance of databases in healthcare worthwhile? An example of a unique, population-based, radiation therapy database. Healthc Q (2012) 0.83
Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer. Int J Radiat Oncol Biol Phys (2003) 0.83
Pretreatment PSA velocity as a predictor of disease outcome following radical radiation therapy. Int J Radiat Oncol Biol Phys (2007) 0.83
A phase II trial of a neoadjuvant platinum regimen for locally advanced breast cancer: pathologic response, long-term follow-up, and correlation with biomarkers. Clin Breast Cancer (2009) 0.82
Increased use of regional radiotherapy is associated with improved outcome in a population-based cohort of women with breast cancer with 1-3 positive nodes. Radiother Oncol (2010) 0.82
Are columnar cell lesions the earliest histologically detectable non-obligate precursor of breast cancer? Virchows Arch (2008) 0.82
Population-based validation of a policy change to use long-term androgen deprivation therapy for cT3-4 prostate cancer: impact of the EORTC22863 and RTOG 85-31 and 92-02 trials. Radiother Oncol (2013) 0.81
Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors. Mod Pathol (2012) 0.81
Endometrial stromal sarcomas with sex cord differentiation are associated with PHF1 rearrangement. Am J Surg Pathol (2013) 0.81
Relationships between family physicians' referral for palliative radiotherapy, knowledge of indications for radiotherapy, and prior training: a survey of rural and urban family physicians. Radiat Oncol (2012) 0.81
DNA ploidy measured on archived pretreatment biopsy material may correlate with prostate-specific antigen recurrence after prostate brachytherapy. Int J Radiat Oncol Biol Phys (2013) 0.81
Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer. Int J Radiat Oncol Biol Phys (2007) 0.81
Inflammatory pseudotumours in the abdomen and pelvis: a pictorial essay. Can Assoc Radiol J (2013) 0.80
Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy. Int J Radiat Oncol Biol Phys (2011) 0.80
Estimating the benefit and cost of radiotherapy for lung cancer. Int J Technol Assess Health Care (2004) 0.79
Thymoma: a population-based study of the management and outcomes for the province of British Columbia. J Thorac Oncol (2013) 0.79
Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada. J Thorac Oncol (2012) 0.79
Management and outcomes of isolated axillary node recurrence in breast cancer. Arch Surg (2006) 0.79
ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors. Am J Surg Pathol (2016) 0.78
Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas. Int J Gynecol Pathol (2014) 0.78
Urinary incontinence in prostate cancer patients treated with external beam radiotherapy. Radiother Oncol (2005) 0.78
An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer. Int J Radiat Oncol Biol Phys (2003) 0.78
YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor. Hum Pathol (2012) 0.78
An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer. Int J Radiat Oncol Biol Phys (2002) 0.78
Increasing severity of haematuria with successive pregnancies in a woman with renal angiomyolipoma. Int Urol Nephrol (2006) 0.78
pN0(i+) breast cancer: treatment patterns, locoregional recurrence, and survival outcomes. Int J Radiat Oncol Biol Phys (2013) 0.77
Osteosarcoma arising from a haemangioma: case report and review of the literature. Turk Patoloji Derg (2014) 0.77
Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection. Int J Radiat Oncol Biol Phys (2011) 0.76
Patient-reported Long-term Cosmetic Outcomes Following Short Fractionation Whole Breast Radiotherapy With Boost. Am J Clin Oncol (2016) 0.76
Radical prostatectomy versus observation for prostate cancer. N Engl J Med (2012) 0.75
Clinical impact of pathology reviews of outside material: a patient-focused approach. J Clin Oncol (2011) 0.75
The negative predictive value of ultrasound-guided 14-gauge core needle biopsy of breast masses: a validation study of 339 cases. Cancer Imaging (2012) 0.75
Sink or Night Float: University of British Columbia Radiology Residents' Experience With Overnight Call. Can Assoc Radiol J (2015) 0.75
Patient satisfaction after the redesign of a chemotherapy booking process. Healthc Q (2012) 0.75
Peer Review in Radiology: How Can We Learn From Our Mistakes? Can Assoc Radiol J (2017) 0.75
Process data: a means to measure operational performance and implement advanced analytical models. Stud Health Technol Inform (2009) 0.75
A Pictorial Review of Hepatobiliary Magnetic Resonance Imaging With Hepatocyte-Specific Contrast Agents: Uses, Findings, and Pitfalls of Gadoxetate Disodium and Gadobenate Dimeglumine. Can Assoc Radiol J (2017) 0.75
Hemoglobin levels do not predict biochemical outcome for localized prostate cancer treated with neoadjuvant androgen-suppression therapy and external-beam radiotherapy. Int J Radiat Oncol Biol Phys (2006) 0.75
The Bethesda System for Reporting Thyroid Fine-Needle Aspiration Cytology: A Kuwaiti Experience - A Cytohistopathological Study of 374 Cases. Acta Cytol (2015) 0.75
Biochemical control with radiotherapy improves overall survival in intermediate and high-risk prostate cancer patients who have an estimated 10-year overall survival of >90%. Int J Radiat Oncol Biol Phys (2011) 0.75